Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06552923 · ClinicalTrials.gov registry record · NA
Extension for Community Health Outcomes (ECHO) Diabetes Program
A NA study of Type 2 Diabetes and Type 1 Diabetes, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 32,796
- Enrollment target
- 17
- Study locations
NCT06552923: Completed NA study of Type 2 Diabetes and Type 1 Diabetes, sponsored by University of Florida.
NCT06552923 is a NA study of Type 2 Diabetes and Type 1 Diabetes that has completed, run by University of Florida. The registered enrollment target is 32,796 participants, above the 3,823-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (758% higher). The trial reports 17 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06552923, a NA study of Type 2 Diabetes and Type 1 Diabetes, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 32,796 participants
- Enrollment target
- 17
- Study locations
Study Summary
The Project ECHO model is currently used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach using a "hub" and "spoke" learning model. Few studies have rigorously evaluated the impact of the program on patient outcomes using randomized designs. This study evaluated implementation of an ECHO Diabetes program on patient-level, provider-level, and center-level outcomes in underserved populations receiving diabetes care from primary care providers. Participants: Twenty Federally Qualified Health Centers (FQHCs) and FQHC "look alikes" across CA and FL were recruited to participate as spokes in the ECHO Diabetes trial. A stepped-wedge trial design was used with randomized, phased-in intervention entry for participating health centers (or "spokes"). Interventions: Spokes were provided access to 6-months of tele-education sessions with continuing medical education credits, access to real-time support for complex medical decision making with hub subspecialty teams, and access to a diabetes support coach. Main outcomes and Measures: Participating FQHCs ("spokes") provided aggregate data including Healthcare Effectiveness Data and Information Set (HEDIS) reporting on the % of patients with HbA1c \>9%.
Primary Outcome
The percent of patients with HbA1c greater than 9 percent
Conditions Studied
Interventions
- OTHER ECHO Tele-Education
Study Locations (17)
California
- CommuniCare Davis Family Health Center - Davis
- St Agnes Medical Center - Fresno
- La Clinica - Multiple Locations
- Santa Rosa Community Health Centers - Multiple Locations
- Shasta Community Health Centers - Multiple Locations
- Health Service Alliance - Rancho Cucamonga
- Hill Country Community Clinic - Redding
- CommuniCare Salud Family Health - West Sacramento
- CommuniCare Hansen Family Center - Woodland
Florida
- Premier Community Health - Dade City
- Community Health of South Florida (CHI) - Homestead
- Banyan Health Systems - Miami
- Borinquen Medical Center - Miami
- Orange Blossom Family Health - Orlando
- Evara Health System - Pinellas Park
- Tampa Family Health Center - Tampa
- Treasure Coast Community Health - Vero Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32,796 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT06552923 record still lists
NCT06552923 is an interventional study that assigns participants to a tested intervention. Its 32,796 participants enrollment target places it among the larger protocols in the corpus, above the 3,823-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (758% higher).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which ECHO Tele-Education is the first listed.
NCT06552923 lists 17 locations in 2 states (California, Florida).
Frequently Asked Questions
What is clinical trial NCT06552923 about?
NCT06552923 is a clinical study titled "Extension for Community Health Outcomes (ECHO) Diabetes Program". The Project ECHO model is currently used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach using a "hub" and "spoke" learning model. Few studies have rigorously evaluated the impact of the program on patient outcomes using randomized designs. Th...
What is the current status of trial NCT06552923?
This trial is currently completed. It is a NA study. The enrollment target is 32,796 participants. The study started on 2021-06-01. Estimated completion is 2023-12-31.
What conditions does trial NCT06552923 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Type 1 Diabetes.
What interventions are being tested in trial NCT06552923?
The interventions under investigation include: ECHO Tele-Education (OTHER).
Who is sponsoring clinical trial NCT06552923?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06552923 being conducted?
This trial has 17 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06552923's enrollment target sits among peer trials
32,796 5th of 327 higher than 323 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI